Overview

Investigation of Interactions Between Faldaprevir, Itraconazole, Atorvastatin and Rosuvastatin

Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
To investigate the effect of steady-state itraconazole on the pharmacokinetics of steady-state of faldaprevir and the effect of steady-state of faldaprevir on the single-dose pharmacokinetics of atorvastatin as well as the effect of steady-state of faldaprevir on the single-dose pharmacokinetics of rosuvastatin
Phase:
Phase 1
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Atorvastatin
Atorvastatin Calcium
Hydroxyitraconazole
Itraconazole
Rosuvastatin Calcium